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THE FEEDBACK CONTROL OF CHOLESTEROL BIOSYNTHESIS* 
W. T. BEHER**, G . D . BAKER**, W . L . ANTHONY**, AND M . E . BEHER** 
The 29 carbon alicyclic alcohol, cholesterol, participates in the metabolic reactions 
of a wide spectrum of cells. It is a precursor of the steroid hormones synthesized 
by ovarian, testicular, placental, and adrenal cortical tissuesV It is rapidly metabolized 
by liver cells to bile acids, which in turn have important influences on intestinal 
absorption'-^ Cholesterol has been implicated in the transport of unsaturated fatty 
acids in the blood and in the regulation of the transfer of fatty acids across the cell 
membrane"*; its role in the structure and metabolism of the nervous system has 
received at least preliminary investigation^ Although these functions are obviously 
vital to the metabolic and structural integrity of the living organism, it is the ob-
normally high blood and tissue cholesterol levels found in the disease, atherosclerosis, 
that is responsible for the present vigorous research interest in cholesterol metabolism. 
Since we are concerned with the etiology and reduction of abnormally elevated 
tissue cholesterol levels in atherosclerosis, it would seem that basic research on the 
mechanisms by which various tissues maintain normal cholesterol levels should be 
of prime importance. Such studies necessarily involve factors influencing and con-
trolling the relative rates of cholesterol anabolism, catabolism and distribution in 
many tissues. As an example, consider a very simple case: the ability of a given 
tissue to maintain a static cholesterol level in an isolated system such as a tissue 
slice or a homogenate. In such a system, the rate of synthesis simply must balance 
the rate of degradation; i . e. if the rate of degradation is increased, the rate of 
synthesis must increase equally or a net decrease in cholesterol level will take place. 
In the intact animal such a simple system does not exist. Here we must consider 
not only relative rates of anabolism and catabolism but also such factors as level 
of dietary cholesterol, rate of exchange of tissue and organ cholesterol with the 
blood, rate of enterohepatic recirculation, intestinal absorption, availability of choles-
terol precursors, availability of certain coenzymes, and possibly the existence of 
active and inactive forms of cholesterol'. Since various hormones can cause altera-
tions in the relative contributions of these and other parameters, we can see the 
enormous complexity of the problem. Obviously in any systematic study of these 
phenomena, one aspect at a time should be investigated while attempting to maintain 
a steady-state with respect to other variables. The following discussion will be 
limited to a consideration of the control of cholesterol biosynthesis by cholesterol 
itself and by the bile acids. 
CHOLESTEROL FEEDBACK INHIBITION 
Since enzymatic reactions may be retarded by (a) specific reaction product 
inhibitions or (b) reversal by accumulated reaction products, one would expect that 
cholesterol formation would be controlled by cholesterol or intermediates in cholesterol 
synthesis. A number of papers have appeared which show that, in various species. 
*The authors' work was supported in part by a grant from the Michigan Heart Association and 
by research grant No. H-5085 (Met), from the National Institutes of Health, U.S. Public Health 
Service. 
**Edsel B. Ford Institute for Medical Research, Biochemistry Department. 
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increases in liver cholesterol levels brought about by dietary cholesterol supplements, 
lead to striking decreases in the ability of the liver to synthesize cholesteroF Con-
versely, decreasing hepatic cholesterol levels by bile duct cannulation^^ triton" ™, lymph 
duct cannulation'!'", x-radiation'"-'', or hyodeoxycholic acid'" results in many fold 
increases in hepatic cholesterol synthesis rates, despite the strikingly different mecha-
nisms involved. In studies on the effects of some of these procedures"-'"-'^  in various 
tissues, it appeared that, with the exception of the adrenal, they had little, if any, 
effect on extrahepatic cholesterol synthesis rates. This suggests that these rates are 
controlled by factors other than those controlling liver cholesterol synthesis. In 
mice or rats fed cholesterol or hyodeoxycholic acid", we detected little change in 
cholesterol levels in tissues other than liver and blood. Recently, however, Morris 
and Chaikoff", employing a different approach to this aspect of the problem, con-
cluded that dietary cholesterol does have an effect on extrahepatic cholesterol synthesis 
in all tissues studied except testes. Further experiments will be necessary to clarify 
this problem, as the details of cholesterol synthesis in extrahepatic tissues may differ 
significantly from those encountered in liver, and few studies have been made of the 
sequence of reactions in these tissues. 
Frantz et aP' showed that there is an inverse relationship between the logarithm 
of the rate of cholesterol biosynthesis and the total cholesterol concentration in rat 
liver slices. Gould" refined this work and found that the rate of hepatic cholesterol 
synthesis is more directly related to free cholesterol concentration than to total 
cholesterol. Neither of these approaches however explains the rapid changes in choles-
terol synthesis rates obtained during the initial phases of cholesterol administration'" or 
lymph duct cannulation'^ ", which are unattended by measurable alterations in hepatic 
cholesterol concentration. It might be suggested that the changes in cholesterol syn-
thesis are probably more related to the cholesterol concentration in or at the surface 
of specific cellular particulates than to the concentration of ester, free, or total 
cholesterol in a given liver. 
Recentiy Siperstein" has shown that the addition of emulsions of cholesterol or 
cholesterol esters to rat tissue slices, synthesizing cholesterol from acetate-l-C", has 
little if any effect on the synthesis rate as long as the cholesterol concentrations are 
held within physiological limits. The validity of these in vitro experiments may be 
questioned on the grounds that there is some doubt whether the cholesterol or 
cholesterol ester in the artificial emulsions used in this study were able to penetrate 
or permeate cell or particulate membranes. Studies using either lipoproteins rich in 
cholesterol or a series of different types of emulsions would increase the value of 
these observations. 
SITE OF CHOLESTEROL FEEDBACK INHIBITION 
Since the sequence of reactions involved in the synthesis of cholesterol from 
acetate (with the exception of those reactions between lanosterol and cholesterol) 
are rather well defined (Fig. I ) " - "^ and since several C'"-labeled compounds in the 
sequence are available, attempts have been made to pinpoint the reaction inhibited 
by cholesterol. In an in vitro investigation, Gould and Popjak" found that homo-
genates prepared from livers of cholesterol-fed rats, incorporated acetate-l-C" into 
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Figure 1 
Pathway of cholesterol biosynthesis from acetate. 
cholesterol much more slowly than homogenates from normal rats, while the rate 
of incorporation of mevalonic acid-2-C!" was not affected. On the other hand inhi-
bition between mevalonic acid and cholesterol has been detected in other investigations. 
Siperstein and co-workers'"--'-" found an inhibition of 30 to 40% in liver slice 
experiments; while Bucher et a/'" detected somewhat more inhibition in homogenates. 
The latter observations, however, represent only two tests. Bucher and co-workers 
also investigated the effect of cholesterol on the conversion of squalene to cholesterol, 
and detected some inhibition. This observation is not in agreement with Siperstein's 
experiments". Study of cholesterol synthesis rates in microsomes and supernatant 
fractions isolated from homogenates derived from livers of normal and cholesterol-fed 
rats led to a series of interesting observations'"; (a) cholesterol synthesis from acetate 
or mevalonic acid depends on the presence of both microsomes and the supernatant 
fraction; (b) combination of the supernatant and microsomes from liver homogenates 
derived from cholesterol-treated rats results in very little cholesterol synthesis from 
acetate; (c) combination of liver microsomes from cholesterol-treated rats with 
liver supernatant from normals results in very little cholesterol synthesis; (d) com-
bination of liver microsomes from normal rats with liver supernatants derived from 
cholesterol-treated rats results in a near normal rate of incorporation of acetate 
into cholesterol. Thus, the effect of cholesterol on cholesterol synthesis influences 
some parameter carried in the microsomes. This may be a series of enzyme reactions, 
a single reaction, or a biophysical change in microsomal structures and/or perme-
abilities. 
In an effort to study some of these effects in in vivo systems, our group 
investigated the influence of cholesterol feeding on the incorporation of acetate-l-C" 
and mevalonic acid-2-C" into mouse liver cholesterol. The results, shown in Table I , 
indicate that while cholesterol synthesis from acetate-l-C" is depressed 95%, meva-
lonic acid-2-C" incorporation is depressed 50% in the several groups. Purification 
of the digitonide precipitate fraction via the dibromide", which removes digitonin 
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Table I 
Influence of Diets Supplemented with 1% Cholesterol on Mouse Liver 
Cholesterol Levels and Synthesis Rates as a Tim.e Function 
Diet Liver Cholesterol Acetate-l-C" Mevalonic Acid-2-C" Incorporation 
Interval Level Incorporation Before Dibiomide After Dibromide 
Purification Purification 
Days mg/g Cholesterol counts per minute per gram tissue 
0 4.22 ± 0.9 2,496 22,729 19,774 
4 8.81 ± 1.87 125 11,106 5,886 
14 12.3 ± 2.85 1.V5 8,703 4,265 
21 15.2 ± 4.14 129 10,496 5,248 
precipitable cholesterol precursors, results in a further loss of activity, bringing the 
inhibition of mevalonic acid-2-C" incorporation to about 75%. This still may not 
be a maximal figure, for the dibromide purification is not quantitative". Moreover, 
the control group of animals, with which the cholesterol-fed group was compared, 
may have totally exhausted the small amount of injected mevalonic acid-2-C" by 
conversion to cholesterol during the one-hour incorporation. While further investiga-
tions will be necessary to establish its full extent, obviously the inhibition of mevalonic 
acid-2-C" incorporation, while not as large as that of acetate-l-C", is substantial. 
The inhibition must lie in the steps from lanosterol to cholesterol, since dibromide 
purification, which removes digitonin precipitable 3^-hydroxysterols from lanosterol 
through desmosterol, results in a loss of C" activity. Therefore the metabolism of 
some cholesterol precursor between squalene and cholesterol is being inhibited. Gould" 
demonstrated inhibition of the conversion of mevalonic acid to cholesterol by chole-
sterol in vivo in rats, but did not purify the isolated cholesterol digitonide. 
The effects of some of the possible intermediates between mevalonic acid and 
cholesterol on biosynthesis of cholesterol from acetate have also been investigated. 
Feeding squalene, lathosterol, or 7-dehydrocholesterol inhibits cholesterol synthesis"-", 
while lanosterol and farnesol are ineffective. Farnesoic and geranoic acids, which 
are probably products of an alternate pathway of squalene metabolism, inhibit the 
conversion of mevalonic acid and farnesyl pyrophosphate to sterols'". Farnesoic acid 
inhibits the conversion of mevalonic acid to 5-phosphomevalonic acid". Therefore 
the formation of these acids has been suggested as a possible control mechanism in 
sterol synthesis". 
The foregoing observations have been interpreted in two ways: (a) Since the in-
hibition of cholesterol synthesis by feedback is much greater from acetate than from 
mevalonic acid or squalene, the main inhibition must lie prior to mevalonic acid; and 
further since acetyl Co A, acetoacetyl Co A, and hydroxymethylglutaryl Co A are all 
involved in vital reactions other than cholesterol syntheis (Fig. 2), which proceed un-
inhibited during the feedback, the only reaction where inhibition is likely is the con-
version of hydroxymethylglutaryl Co A to mevalonic acid, a relatively nonreversible 
reaction. Lynen and coworkers"" showed that this reaction was inhibited under feedback 
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Figure 2 
Metabolic interrelationships in cholesterol feedback inhibition. 
conditions, (b) It is possible to regard the smaller feedback inhibition, mevalonic acid 
/ / — ^ cholesterol, as very important. The reaction sequence acetate 
>• mevalonic acid >• cholesterol, can be divided as follows: The meta-
bolites prior to mevalonic acid are readily interconvertible (Fig. 2) , and in two cases, 
viz. acetyl Co A and acetoacetyl Co A, are among the substrates most in demand for a 
variety of major synthesis pathways. In contrast, mevalonic acid seems to have little 
future save incorporation into isoprenoid compounds and subsequently into the steroid 
nucleus. That which can not be utilized is excreted unchanged."' Therefore during 
feedback inhibition, a uniform feedback all along the sequence of reactions would 
appear much greater if studied with acetate-l-C" than it would appear if studied with 
mevalonic acid-2-C" because the acetate-l-C" would disappear more rapidly into 
other major pathways while the mevalonic acid-2-C" would be rapidly converted 
to cholesterol*. 
BILE ACID FEEDBACK INHIBITION 
The feedback reaction we have been considering up to this point may be indi-
cated in the following way: 
(a) Acetate Cholesterol 
i.e., cholesterol prevents its own synthesis by inhibiting a reaction or reactions between 
acetate and cholesterol. i 
Cholesterol is eliminated from an organism in a number of ways: (a) excretion 
in the fecal sterol fraction, (b) conversion to bile acids followed by fecal elimination, 
(c) loss by exfoliation of tissues containing the sterol, (d) metabolism to the steroid 
hormones with subsequent excretion, and (e) excretion in the sebum. Pathways (a) 
and (b) account for most of the elimination. I f we once again turn to the concepts 
of product inhibition and reaction reversal, it might be expected that the fecal sterols 
and bile acids would limit the conversion of cholesterol to these endproducts by 
feedback reactions, such as the following: 
•••Only one isomer of dl-mevalonic acid is utilized for steroid synthesis. Therefore a maxiinum of 
50% dl-mevalonic acid could be converted to cholesterol. 
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(b) Cholesterol fecal sterols (c) cholesterol 
- > bile 
acids 
With respect to feedback b, the fecal sterols have an extrahepatic origin. They may 
be synthesized in several extrahepatic tissues, but the small intestine is the probable 
point of origin of the bulk of these substances. Recently Danielsson"' has suggested 
that the synthesis of these sterols may be controlled by a feedback reaction similar to b. 
Reaction c has been investigated at least preliminarily. Eriksson"' found that the 
normal rat produces around 5 to 6 mg per day of bile acid. I f a tube is placed in the 
bileduct of a normal rat and led to the outside so that the bile acids which normally 
enter the enterohepatic recirculation are eliminated (bile duct fistula), the rate of bile 
acid production increases 10 fold. This is indirect evidence inasmuch as an animal 
under these conditions is abnormal. Bergstrom and Danielsson"" more recentiy have 
shown that if one administers taurochenodeoxycholic acid (one of the two main 
bile acid conjugates of rat bile) to bile fistula rats, the bile acid excretion is lowered 
from around 60 mg per day to between 5 and 10 mg per day. 
We have studied this feedback reaction in intact mice with elevated hepatic 
cholesterol levels"^ Cholesterol-4-C" was administered orally until the specific activity 
of the liver cholesterol pool was constant and liver cholesterol levels elevated. Feces 
were collected and the C" activity of the bile acid and sterol fractions determined 
as a function of time. Cholic acid (Fig. 3) retarded the excretion of bile acids at 
all time intervals. There was littie or no effect on the fecal sterol excretion. While 
the animals used in this study were intact, they did have elevated hepatic cholesterol 
levels and there is some doubt that this pool is representative of the pool in normal 
animals because of the presence of a high concentration of cholesterol esters"'. We 
therefore investigated the effect of cholic acid on the fecal bile acid output in normal 
animals receiving a single injection of mevalonic acid-2-C". The results showed that 
cholic acid inhibits bile acid production by about 50% in the normal mouse"'. 
Whitehouse and Staple"' studied the inhibition of cholesterol degradation in vitro, and 
found that C"02 production from cholesterol-26-C" metabolized by a liver mitochondrial 
suspension, is retarded by the taurine and glycine conjugates of cholic acid. Danielsson"' 
has recently pointed out that many reactions occurring during the conversion of 
cholesterol to bile acids in mitochondrial suspensions in vitro are due to auto-oxidation, 
are non-enzymatic, and do not correspond to in vivo reactions. Therefore observations 
on the production of C"02 from cholesterol-26-C" are suspect when applied to 
rate studies. 
Scant attention has been given to the site of bile acid inhibition of reactions 
in sequence c from cholesterol to bile acids. Whitehouse and Staple"' found that 
the metabolism of 3a, la , 12a-trihydroxycoprostane-27-C" (an intermediate between 
cholesterol and the bile acids) measured by C"02 production, was inhibited less by 
tauro- and glyco-cholic acids than the metabolism of cholesterol-26-C". However, as 
mentioned above, doubt can be cast on the validity of using C"02 as an indicator 
of bile acid formation. 
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Figure 3 
Fecal excretion of Ci*-labcled steroids in normal and cholic acid 
treated mice with elevated tissue cholesterol-4-C'< 
The use of free bile acids in metabolic studies has been questioned by Berg-
strom™. He points out that since free bile acids are rapidly conjugated with taurine 
or glycine in the liver, their use may exhaust the supply of sulfur-containing amino 
acids, glycine, and serine, and thus upset normal hepatic metabolic patterns. While 
this is undoubtedly true, recent in vivo experiments'' (Fig. 4) indicate very little 
difference between the effects of free and conjugated bile acids on cholesterol meta-
bolism when administered at the 0.5% level. 
THE DOUBLE FEEDBACK INHIBITION OF CHOLESTEROL BIOSYNTHESIS 
Thus far we have been considering feedback reactions involving cholesterol or 
the bile acids as separate entities. However, if these two reactions are coupled a 
double feedback reaction (shown below), which may be important in controlling 
cholesterol metabolism, can be visualized. 
Acetate cholesterol 
I I 
bile acid 
Here an increase in bile acid concentration would retard reaction sequence c leading 
to an increase in the cholesterol level, which would in turn inhibit reaction sequence a. 
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Figure 4 
The effects of free and conjugated cholic acid on mouse liver cholesterol levels 
and synthesis rates (cholesterol-x-C^'' levels). 
Such a feedback system presumably would be effective only in the liver, since 
cholesterol oxidation to bile acids is only significant in hepatic cells'" and feedback 
reaction a appears to occur only in the liver and possibly the adrenals. 
The following experimental evidence supports the double feedback hypothesis. 
Swell et a/" noted that 24 hours after cannulation of the bile duct of rats, cholesterol 
synthesis was increased 10 fold. Inasmuch as there is about a 10 fold increase 
in bile acid production at the same time"', this is at least indirect evidence in favor 
of the double feedback reaction. Work done by the authors'"-"'- has provided 
considerable evidence in favor of this sequence. The previously discussed experiments, 
illustrated in Figure 3, show that cholic acid inhibits reaction sequence c, the con-
version of cholesterol to the bile acids. If the double feedback hypothesis is correct, 
cholic acid administration should lead to increases in hepatic cholesterol levels and 
decreases in liver cholesterol synthesis rates. To investigate this point, mice or rats 
were fed basal diets supplemented with cholic acid, taurocholic acid or glycocholic 
acid. The animals received intraperitoneal injections of acetate-1-C", were sacrificed 
and liver cholesterol and cholesterol-x-C" levels determined. The results (Fig. 4) 
show that cholic acid and its glycine and taurine conjugates increase liver cholesterol 
levels and decrease the rate of cholesterol synthesis (inhibition a). That the decrease 
in cholesterol synthesis was due to the increased level of hepatic cholesterol was 
shown by a further experiment (Fig. 5). When liver cholesterol levels, synthesis 
rates and bile acid levels were determined as a function of time, increases in bile 
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acid and cholesterol levels were in phase and correlated well with decreases in hepatic 
cholesterol synthesis rates (cholesterol-x-C" levels). 
If the double feedback reaction is valid, cholic acid or its conjugates should 
not inhibit directly at a. This point was investigated by Siperstein" who demonstrated 
that in vitro cholesterol synthesis in rat liver slices is not inhibited by cholic acid 
or its conjugates per se. Taken as a whole, there is considerable evidence in favor 
of the double feedback reaction. 
APPLICATIONS OF THE FEEDBACK INHIBITIONS 
Various attempts have been made to apply these basic findings to the problem 
of control of tissue cholesterol levels. It has been demonstrated, for example, that 
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Figure 5 
The effect of cholic acid on cholesterol, cholesterol-x-C", 
and serum bile acid levels as a function of time. 
• Liver cholesterol. O Serum bile acid, x Liver choIesterol-x-C* 
intestinal micro-organisms have important effects on bile acid turnover rates. Gustafsson 
and co-workers"-" found that in germ free rats the normal bile acid turnover rate 
of 5 to 6 days is doubled. Under germ free conditions, rat blood cholesterol is 
elevated". Various antibiotics, which alter and decrease intestinal flora concentrations, 
increase serum cholesterol levels'" presumably by decreasing the conversion of 
cholesterol to bile acids. 
Attempts have been made to lower blood cholesterol levels by increasing bile 
acid excretion rates, and in turn increasing cholesterol catabolism. Siperstein et o/'"'" 
observed that diets containing 3% ferric chloride (which precipitates bile acids in vitro) 
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limited the rise in blood cholesterol and the severity of atherosclerosis in cholesterol-
fed cockerels. More recent experiments""" show that ferric ions are ineffective in 
preventing cholesterol absorption or increasing the rate of conversion of cholesterol 
to bile acids in mice and rats. Setty and Ivy" studied the effect of aluminum 
phosphate gel in rats and found no significant increase in bile acid excretion. Rodbard" 
had eariier reported a decrease in blood cholesterol and atherosclerosis in chickens 
fed similar gels. In any case, the use of metal ions is limited by toxicity. Effects 
of anion exchange resins, which sequester bile acids in vitro systems, have been in-
vestigated in vivo. Tennent et aP showed that MK-325 and MK-135, (polymeric 
organic bases) inhibit blood cholesterol increases and aortic plaque formation in 
cholesterol-fed cockerels. These resins also lower blood cholesterol levels and increase 
fecal sterol and bile acid excretion in dogs. Feeding MK-135 to rats did not lower 
blood cholesterol, possibly because of the relatively greater ability of the rat to 
synthesize hepatic cholesterol". Setty and Ivy" investigated several compounds of 
this type; most increased bile acid excretion to some extent. MK-135 has been found 
to induce steatorrhea in human subjects". 
Hyodeoxycholic acid is another interesting substance. This compound is unique 
in that it effectively lowers blood and liver cholesterol levels'"-""" in mice by increasing 
the excretion of fecal sterols"'. In this case part c of the double feedback reaction 
is bypassed. In normal mice, hyodeoxycholic acid or its glycine conjugate increases 
fecal sterol output about 3 fold"'. Hyodeoxycholic acid has no demonstrable effect 
on rat hepatic cholesterol synthesis rates"', while it increases this parameter in mice 
3 to 6 fold". A species difference appears to exist. 
Littie is known concerning the role of defects in the feedback reactions in 
various diseases which affect cholesterol levels. Recently Dubach and co-workers" 
investigated this problem in experimentally nephrotic rats, and found that the feedback 
mechanism responds to dietary cholesterol in an essentially normal fashion in these 
animals. 
CONCLUSIONS 
1. It has been shown by various approaches that in hepatic tissue the rate of 
cholesterol biosynthesis is controlled by the cholesterol level. There is conflicting 
evidence concerning the effect of cholesterol on cholesterol synthesis rates in extra-
hepatic tissues. 
2. The feedback inhibition of cholesterol synthesis may take place at several 
steps in the cholesterol synthesis sequence. It appears that the major point of 
inhibition is at the conversion of hydroxymethylglutaryl Co A to mevalonic acid; 
however, strong inhibitions are also effected between mevalonic acid and cholesterol. 
3. The rate of conversion of cholesterol to bile acid is also controlled by 
feedback inhibitions, but few studies have been reported in connection with the site 
of inhibition in this sequence of reactions. 
4. The cholesterol feedback reaction and bile acid feedback reaction are coupled 
in in vivo systems, resulting in a double feedback reaction sequence. Study of 
factors affecting this double feedback reaction may help to explain abnormal cholesterol 
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levels in various metabolic disturbances, and offers a promising approach to the 
problem of controlling tissue cholesterol levels. 
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